Hyam Levitsky - Apr 12, 2023 Form 3 Insider Report for Century Therapeutics, Inc. (IPSC)

Role
President of R&D
Signature
/s/ Michael Diem, Attorney-in-Fact
Stock symbol
IPSC
Transactions as of
Apr 12, 2023
Transactions value $
$0
Form type
3
Date filed
4/14/2023, 07:55 PM
Previous filing
Apr 4, 2023
Next filing
Mar 11, 2024

Transactions Table

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding IPSC Stock Option (right to buy) Apr 12, 2023 Common Stock 7.87K $7.27 Direct F1
holding IPSC Stock Option (right to buy) Apr 12, 2023 Common Stock 26.3K $13.15 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 As of the date hereof, these stock options are vested and currently exercisable.

Remarks:

Exhibit 24.1 - Power of Attorney (incorporated by reference to Exhibit 24.1 to the original Form 3 filed by the Reporting Person on June 17, 2021).